Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
19 February 2015 |
Main ID: |
NCT01532466 |
Date of registration:
|
07/02/2012 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
The Effect of Priming Intravenous Rocuronium on Fentanyl-Induced Coughing
|
Scientific title:
|
|
Date of first enrolment:
|
March 2011 |
Target sample size:
|
260 |
Recruitment status: |
Completed |
URL:
|
http://clinicaltrials.gov/show/NCT01532466 |
Study type:
|
Interventional |
Study design:
|
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Prevention
|
Phase:
|
N/A
|
|
Countries of recruitment
|
Taiwan
| | | | | | | |
Contacts
|
Name:
|
Chih-Shung Wong, PhD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Cathay General Hospital |
| | |
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- 260 ASA I-II patients,
- aged between 18 and 80 years, and undergoing various elective surgeries at Taichung
Armed Forces General Hospital.
Exclusion Criteria:
- a history of asthma,
- chronic cough,
- smoking,
- upper respiratory tract infection in the previous 2 weeks, and
- medication containing angiotensin-converting enzyme inhibitors or anesthetic
premedication.
Age minimum:
18 Years
Age maximum:
80 Years
Gender:
Both
|
Health Condition(s) or Problem(s) studied
|
Fentanyl-induced Coughing
|
Intervention(s)
|
Drug: Rocuronium
|
Primary Outcome(s)
|
Incidence of fentanyl-induced coughing
[Time Frame: 2 minutes]
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|